Chemoinformaics analysis of ANTHRAQUINONE-2-CARBOXYLIC-ACID
| Molecular Weight | 252.225 | nRot | 1 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 19 |
| Exact Molecular Weight | 252.042 | nRing | 3 |
| Solubility: LogS | -3.607 | nHRing | 0 |
| Solubility: LogP | 3.233 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 3 | APOL | 33.5923 |
| nHD | 1 | BPOL | 10.6297 |
| QED | 0.72 |
| Synth | 1.76 |
| Natural Product Likeliness | 0.16 |
| NR-PPAR-gamma | 0.325 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.624 |
| Pgp-sub | 0 |
| HIA | 0.007 |
| CACO-2 | -4.572 |
| MDCK | 0.0000156 |
| BBB | 0.321 |
| PPB | 0.958642 |
| VDSS | 0.266 |
| FU | 0.0129694 |
| CYP1A2-inh | 0.377 |
| CYP1A2-sub | 0.067 |
| CYP2c19-inh | 0.107 |
| CYP2c19-sub | 0.043 |
| CYP2c9-inh | 0.306 |
| CYP2c9-sub | 0.058 |
| CYP2d6-inh | 0.04 |
| CYP2d6-sub | 0.059 |
| CYP3a4-inh | 0.048 |
| CYP3a4-sub | 0.098 |
| CL | 0.728 |
| T12 | 0.406 |
| hERG | 0.102 |
| Ames | 0.311 |
| ROA | 0.095 |
| SkinSen | 0.112 |
| Carcinogencity | 0.798 |
| EI | 0.868 |
| Respiratory | 0.074 |
| NR-Aromatase | 0.025 |
| Antiviral | Yes |
| Prediction | 0.752603 |